Prognostic Value of MGMT Promoter Methylation in Glioblastoma Patients Treated With Temozolomide-Based Chemoradiation: A Portuguese Multicentre Study
Oncology Reports - Greece
doi 10.3892/or_00000808
Full Text
Open PDFAbstract
Available in full text
Date
April 23, 2010
Authors
Unknown
Publisher
Spandidos Publications
